Impact of Recombinant Human Erythropoietin Treatment on Left Ventricular Hypertrophy and Cardiac Function in Dialysis Patients

Publisher： Karger

E-ISSN： 1421-9735|16|6|317-324

ISSN： 0253-5068

Source： Blood Purification, Vol.16, Iss.6, 1999-05, pp. : 317-324

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Left Ventricular Hypertrophy in Incident Dialysis Patients Randomized to Treatment with Hemofiltration or Hemodialysis: Results from the ProFil Study

By  

Blood Purification, Vol. 32, Iss. 1, 2011-01 ,pp. : 21-29

Karger

Access to resources Recommend Favorite

Left Ventricular Hypertrophy in Chronic Kidney Disease Patients: From Pathophysiology to Treatment

By  

Cardiorenal Medicine, Vol. 5, Iss. 4, 2015-0 ,pp. : 254-266

Karger

Access to resources Recommend Favorite

The Prevalence of Hypertension, Valve Calcification and Left Ventricular Hypertrophy and Geometry in Peritoneal Dialysis Patients

By  

Kidney and Blood Pressure Research, Vol. 35, Iss. 6, 2012-06 ,pp. : 431-437

Karger

Access to resources Recommend Favorite

Effect of Angiotensin-Converting Enzyme Inhibitors on Hematological Parameters and Recombinant Human Erythropoietin Doses in Peritoneal Dialysis Patients

By  

Nephron, Vol. 80, Iss. 2, 1998-09 ,pp. : 239-239

Karger

Access to resources Recommend Favorite

Urinary Protein Excretion Is Associated with Left Ventricular Hypertrophy in Treatment-Naïve Hypertensive Patients in an African Hospital Setting

By  

Cardiorenal Medicine, Vol. 3, Iss. 1, 2013-03 ,pp. : 57-62

Karger

Access to resources Recommend Favorite